Q3 Recalls Snapshot: Numbers Continue To Rise; Software, Mislabeling Remain Top Reasons For A Recall
Executive Summary
The number of device recalls continued to climb in 2016, with software and mislabeling causing the most troubles for manufacturers in the third quarter. They were the top two reasons for a recall.
You may also be interested in...
What US FDA’s ‘Emerging Signals’ Guidance Means For Medical Device Manufacturers
Thanks to the relatively new agency guidance document related to emerging medical device signals, consumers and health-care providers will receive more prompt and frequent notifications of potential product risks. But there is potential ambiguity for every stakeholder involved, Michael Good of Stericycle ExpertSOLUTIONS explains in this Medtech Insight guest column.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.